QualityStocksNewsBreaks Archives - Page 292 of 1584

TuesdayJul 02, 2024 10:52 am

QualityStocksNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Releases Q1 2024 Financial Reports, Business Update

Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company focused on the development of inflammation and immunology (“I&I”) biological products and on providing contract development and manufacturing organization (“CDMO”) services through its Scinai Bioservices business unit, is reporting on its financial results for the quarter ended March 31, 2024; the company also released a business update. Notable financial numbers include R&D expenses for the three-month period totaling $1,568,000; marketing, general and administrative expenses totaling $484,000; financial income totaling $231,000; and net loss reported at $2,159,000; the company also reported cash and cash equivalents and short-term deposits of $4,826,000 as of March 31, 2024. Business highlights include raising $1.69 million in gross proceeds…

TuesdayJul 02, 2024 10:25 am

QualityStocksNewsBreaks – NextPlat Corp (NASDAQ: NXPL) Expands E-Commerce Program in China

NextPlat (NASDAQ: NXPL, NXPLW), a global e-commerce provider, today announced that it has expanded its e-commerce development program in China through a new agreement with a leading Chinese healthcare and nutritional products marketing and distribution services partner (the “marketing partner”). According to the update, the marketing partner will provide NextPlat with a full range of creative content, brand marketing and product sales and distribution services and support the company’s exclusive joint e-commerce development agreement with OPKO Health Europe , a subsidiary of OPKO Health, Inc. (NASDAQ: OPK). “Our unique e-commerce development program was created to provide American companies with turn-key…

MondayJul 01, 2024 2:30 pm

QualityStocksNewsBreaks – Golden Triangle Ventures Inc.’s (GTVH) Lavish Moves to Become Staple in the Entertainment Industry

Golden Triangle Ventures’ (OTC: GTVH) Lavish Entertainment embodies GTVH’s focus on vertical integration to cut costs and maximize margins, as evidenced by its recently released four-pillar business model. “According to GTVH, this strategic framework provides an essential piece of Lavish’s mission to create an industry leading entertainment business. The company’s new model includes key foundational elements – logistics, staffing, equipment and production – that were carefully identified and organized to complement each other and ensure seamless operations across all facets of the company. With its new business model as a backdrop, Lavish Entertainment plans to develop and acquire operations in…

MondayJul 01, 2024 1:53 pm

QualityStocksNewsBreaks – Alphabet Inc. (NASDAQ: GOOGL) Partners with BlackRock on Solar Energy Project in Taiwan

Alphabet Inc. (NASDAQ: GOOGL, GOOG), the parent company of Google, has recently made headlines with its strategic partnership with BlackRock to develop a significant solar capacity in Taiwan. This initiative underscores Google’s commitment to sustainability and its efforts to mitigate the environmental impact of its expanding artificial intelligence operations. By investing in New Green Power, a Taiwanese solar developer, Google aims to bolster large-scale solar projects, enhancing energy capacity while reducing carbon emissions. This move, however, is pending regulatory approval, indicating a crucial step before the project’s full realization. The collaboration with BlackRock and the focus on renewable energy come…

MondayJul 01, 2024 1:44 pm

QualityStocksNewsBreaks – PaxMedica Inc. (PXMD) Intensifying Efforts to Achieve Significant Program Milestones

PaxMedica (OTC: PXMD), a biopharmaceutical company specializing in neurological disorders, is preparing to submit a New Drug Application (“NDA”) to the U.S. Food and Drug Administration (“FDA”) for using suramin to treat Human African Trypanosomiasis (“HAT”), a well-established treatment in East Africa for nearly a century. A recent article discussed PaxMedica gearing up for a significant Type C meeting it had with the FDA, which “is critical for the advancement of PAX-101, the company’s leading drug candidate for treating autism, as it progresses through the regulatory framework… For PaxMedica, this Type C meeting is a strategic opportunity to engage with…

MondayJul 01, 2024 12:07 pm

QualityStocksNewsBreaks – Upstream Article Talks Rise of Exchange Markets, Reflecting ‘Market Demand for Innovation’

Upstream, a MERJ Exchange stock market and global trading app, is noting “a push towards more efficient, transparent markets that offer greater access to the everyday investor” in its most recent article. The article notes that while capital markets have traditionally included stock markets such as the New York Stock Exchange, NASDAQ, London Stock Exchange and Tokyo Stock Exchange, there has been an increase in next-generation exchanges, including the TXSE Group, a new national stock exchange based in Dallas. According to the article, the newly formed TXSE Group has plans to file for registration with the U.S Securities and Exchange…

FridayJun 28, 2024 2:23 pm

QualityStocksNewsBreaks – Correlate Energy Corp. (CIPI) Helping Companies ‘Beat the Grid for Costs’

Correlate (OTCQB: CIPI) is a tech-enabled development, finance and fulfillment platform for distributed energy solutions across North America. “Correlate Energy is a unique source for helping make renewable energy accessible to companies seeking to transition from more carbon-intensive fuels as part of a worldwide effort to forestall the harms of pollution-driven changes to the environment. The company’s focus on solar energy infrastructure, for example, is a result of solar’s ability to ‘beat the grid for costs,’ President and CEO Todd Michaels said during an interview earlier this year,” a recent article reads. “Correlate’s leadership team has collectively developed, financed and…

FridayJun 28, 2024 2:00 pm

QualityStocksNewsBreaks – Energy and Water Development Corp.’s (EAWD) Off-Grid Solution Set to Address Water Scarcity Challenges

Energy and Water Development Corp. (OTCQB: EAWD), a green-tech engineering company, is focused on delivering solutions to extreme environments emphasizing self-sufficient energy-supplied water generation and green energy production. With around 60% of Mexico experiencing moderate to exceptional drought and several months to go before the fall rainy season, concerns have arisen that one of the world’s most populous cities, Mexico City, may soon run entirely out of water. “Amid the crisis, ‘several significant landowners of the Magdalena Contreras Municipality’ of Mexico City, where more than 200,000 of the city’s residents live, signed a joint memorandum of understanding (‘MOU’) with Florida-based…

FridayJun 28, 2024 11:01 am

QualityStocksNewsBreaks – DigiAsia Corp. (NASDAQ: FAAS) Closes on $3.6M Private Placement

DigiAsia (NASDAQ: FAAS), a leading Fintech as a Service (“FaaS”) ecosystem provider, has entered into a Securities Purchase Agreement (“SPA”) with a group of investors. According to the agreement, DigiAsia will sell certain Class A convertible promissory notes and Class B convertible promissory notes as well as warrants. The notes, which have a one-year maturity, total up to $8,863,528.24. Each warrant will be a five-year warrant for a number of ordinary shares equal to the principal amount of the Class A note issued to the applicable investor, multiplied by 60% and divided by 120% of the closing price of the ordinary…

FridayJun 28, 2024 10:54 am

QualityStocksNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Awarded Final Judgment, Confirmation of $3M-Plus Arbitration Award

FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions to address ailments affecting millions worldwide, has announced that the United States District Court for the Eastern District of Pennsylvania ruled in favor of FSD Pharma and is granted its motion for entry of judgment against Dr. Raza Bokhari, the company’s former CEO. The decision awards FSD Pharma several awards, including $147,301.04 plus interest at a rate of 4% per annum from Nov. 9, 2022, until the date the judgment is satisfied; C$31,912.55 plus interest at a rate…

Site Search

Company Search

Category: QualityStocksNewsBreaks